Search

PROCEPT BioRobotics Corp

Закрыт

СекторЗдравоохранение

21.69 6.95

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

20.28

Макс.

22.17

Ключевые показатели

By Trading Economics

Доход

-1.8M

-32M

Продажи

6.7M

83M

Прибыль на акцию

-0.56

Рентабельность продаж

-38.058

Сотрудники

888

EBITDA

-7.3M

-29M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

+13.33% upside

Дивиденды

By Acuity

Следующий отчет о доходах

3 нояб. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-325M

1B

Предыдущая цена открытия

14.74

Предыдущая цена закрытия

21.69

Новостные настроения

By Acuity

50%

50%

128 / 340 Рейтинг в Healthcare

PROCEPT BioRobotics Corp График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

10 авг. 2026 г., 19:53 UTC

Procept Biorobotics Corp shares are higher, supported by reduced Fed rate hike expectations following Friday's weaker jobs report. The stock remains above its 20-day moving average.

7 авг. 2026 г., 20:02 UTC

News

Procept Biorobotics shares are higher as analysts adjust ratings; Wells Fargo sets target at $19.00, while UBS downgrades to "neutral" with a $20.00 target.

6 авг. 2026 г., 20:03 UTC

Procept Biorobotics shares are higher Thursday, recovering from an earlier decline. The stock closed above its 20-day moving average amid broader market dynamics.

5 авг. 2026 г., 19:52 UTC

News

Procept Biorobotics shares are higher as TD Cowen maintains a Buy rating and Piper Sandler reiterates its Overweight rating amid increased investor engagement.

4 авг. 2026 г., 23:02 UTC

News

Procept Biorobotics reported a second-quarter loss of $26.9 million and shares are trading lower in after-market hours following the earnings report.

3 авг. 2026 г., 20:03 UTC

News

Procept Biorobotics shares decline amid a securities class action lawsuit alleging financial misrepresentation through inflated sales and excess inventory.

31 июл. 2026 г., 20:02 UTC

News

Procept Biorobotics shares are rising today, even after UBS downgraded its rating to neutral with a $20 price target.

30 июл. 2026 г., 19:58 UTC

Procept Biorobotics Corp is rising during Thursday's session, driven by a broader market rally and recovery in technology shares. No specific company news was identified.

29 июл. 2026 г., 16:26 UTC

Procept Biorobotics Corp shares are higher Wednesday, recovering from earlier losses amid broader market volatility ahead of the Federal Reserve's interest rate decision.

28 июл. 2026 г., 19:26 UTC

Procept Biorobotics Corp shares are trading higher, reflecting a cumulative gain since Monday, despite negative sentiment from declines in Asian markets.

27 июл. 2026 г., 17:02 UTC

News

Procept Biorobotics reported Q1 revenue of $83.1 million, a 20% increase. Shares are trading higher, recovering from recent declines since Friday's close.

22 июл. 2026 г., 19:41 UTC

Procept Biorobotics Corp shares are lower today, diverging from recent gains. Broader market concerns include rising crude oil prices and inflationary pressures.

21 июл. 2026 г., 16:01 UTC

Procept Biorobotics Corp is declining during Tuesday's session, breaking a trend of higher daily closes. No specific news was identified for the move.

20 июл. 2026 г., 19:56 UTC

Procept Biorobotics Corp shares are higher today, despite earlier volatility and no specific news. Broader market performance remains mixed amid geopolitical tensions.

Сравнение c конкурентами

Изменение цены

PROCEPT BioRobotics Corp Прогноз

Целевая цена

By TipRanks

13.33% рост

Прогноз на 12 месяцев

Средняя 23.13 USD  13.33%

Максимум 29 USD

Минимум 19 USD

Основано на мнении 11 аналитиков Wall Street, спрогнозировавших целевые цены для PROCEPT BioRobotics Corp на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

11 ratings

3

Покупка

7

Удержание

1

Продажа

Настроения

By Acuity

128 / 340Рейтинг в Здравоохранение

Новостные настроения

Neutral

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
help-icon Live chat